Local Substudy Associated to the International Study MO19390 to Determine the BRCA1 Gene mRNA Expression as a Predictive Marker of Response to Chemotherapy

Trial Profile

Local Substudy Associated to the International Study MO19390 to Determine the BRCA1 Gene mRNA Expression as a Predictive Marker of Response to Chemotherapy

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Bevacizumab (Primary) ; Cisplatin; Docetaxel; Gemcitabine; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 20 Jan 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 17 Jun 2008 Status changed from initiated to recruiting according to ClinicalTrials.gov.
    • 09 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top